Exploring ultrasound characteristics in breast cancer
Application of Radiomics in Correlation Between Ultrasound Characteristics and Pathological Prognostic Factors in Breast Cancer
This study is trying to see how different ultrasound features of breast cancer relate to important factors in patients receiving hormone therapy to help improve treatment decisions.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University Academic / other |
| Locations | 1 site (Hanzhou, Zhejiang) |
| Trial ID | NCT04483804 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the relationship between various ultrasound characteristics, including conventional, elastography, and contrast-enhanced ultrasound (CEUS), and pathological prognostic factors in patients diagnosed with breast cancer. By utilizing radiomics, the study aims to uncover potential correlations that could enhance understanding of breast cancer pathology. The research focuses on gathering data from patients undergoing endocrine therapy and analyzing it to identify patterns that may inform treatment decisions.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals clinically diagnosed with breast cancer who have complete pathology and follow-up data.
Not a fit: Patients with incomplete pathology results or missing follow-up data may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the accuracy of breast cancer prognostication and treatment planning based on ultrasound characteristics.
How similar studies have performed: While the specific approach of using radiomics in this context may be novel, similar studies have shown promise in correlating imaging characteristics with cancer prognostics.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Clinical diagnosis of breast cancer Exclusion Criteria: Missing pathology Missing follow-up results Missing data
Where this trial is running
Hanzhou, Zhejiang
- the Second Affiliated Hospital Zhejiang University School of Medicine — Hanzhou, Zhejiang, China (Recruiting)
Study contacts
- Principal investigator: pintong Huang — Second Affiliated Hospital, School of Medicine, Zhejiang University
- Study coordinator: zimei Lin
- Email: zimei.lin@zju.edu.cn
- Phone: +8615157171799
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.